Business Context and Reporting Period
Company: Constellation Brands, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 18, 2019
Subject: Modification of warrant terms and rights related to the company's investment in Canopy Growth Corporation ("Canopy").
Key Financial Metrics
This filing does not report standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the structural terms of a specific investment instrument.
Material Changes and Transaction Details
Constellation Brands entered into an agreement to modify the terms of common share purchase warrants in Canopy Growth Corporation (the "CBG Warrants"), originally acquired on November 1, 2018. The modifications are subject to Canopy shareholder approval.
- Original Structure: 88,472,861 Tranche A warrants (C$50.40 exercise price) and 51,272,592 Tranche B warrants (variable exercise price).
- Proposed Modified Structure:
- Tranche A: 88,472,861 warrants; exercise price remains C$50.40; expiration extended to November 1, 2023.
- Tranche B: 38,454,444 warrants; exercise price set at C$76.68; expiration November 1, 2026.
- Tranche C: 12,818,148 warrants; exercise price based on 5-day VWAP; expiration November 1, 2026.
- Share Repurchase Condition: If Canopy fails to purchase 27,378,866 of its common shares for cancellation (up to C$1,582,995,262) within 24 months of Tranche A exercise, the exercise price for Tranche B and C warrants will be reduced by the shortfall amount.
- Acquisition Restriction Lifted: The modification allows Constellation to acquire up to 20,000,000 additional Canopy shares on the open market or privately, with a corresponding reduction in Tranche B or C warrant count. Previously, Constellation was barred from acquiring additional shares until all warrants were exercised or expired.
Outlook, Risks, and Management Commentary
Strategic Context: The changes are driven by Canopy's intention to acquire Acreage Holdings, Inc. upon federal cannabis legalization in the United States.
Contingencies and Risks:
- The modifications are not effective until approved by Canopy shareholders.
- Approval is also required for the separate Acreage Holdings transaction.
- The reduction in exercise prices for Tranche B and C is contingent on Canopy's failure to meet specific share repurchase targets.
Investor Verification Checklist
- Verify the status of Canopy Growth Corporation shareholder votes regarding the warrant modifications and the Acreage Holdings acquisition.
- Monitor Canopy's share repurchase activity to determine if the C$1.58 billion threshold is met, which impacts the exercise price of Tranche B and C warrants.
- Review the impact of the new open market acquisition allowance on Constellation's total ownership percentage in Canopy.
- Confirm the timeline for the expiration of the modified warrants (2023 for Tranche A; 2026 for Tranche B and C).